Avery Biomedical Devices, a manufacturer in Commack, is changing the lives of people around the world with its industry-leading technology: the diaphragm pacemaker. The company’s Avery Breathing ...
A second clinical trial of a diaphragm pacer for people with ALS has shut down early, and another hangs in limbo, as doctors and patients wonder if the surgically implanted device—meant to improve ...
ATLANTA — Local doctors are making history. They implanted a diaphragm pacemaker into a 14-year-old boy. This is the first time this surgery has been done in Georgia. Now with the new mechanism ...
April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...
October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...
It helped the late “Superman” actor Christopher Reeve, who was paralyzed by a spinal cord injury, breathe at times without using a mechanical ventilator. Now, the diaphragm pacing system is helping ...
ALS patients using diaphragm pacing experienced improved quality of life, with better sleep and daytime functioning, better breathing, and less fatigue. Respiratory failure is one of the major ...
Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis (ALS) and respiratory insufficiency, show findings from a randomised ...
Laparoscopic diaphragm mapping – an electronic reading of the diaphragm nerves – is safe and can be performed in multiple centers with success, a new study shows. Early diaphragm mapping can quickly ...
CLEVELAND — Medical technology that was created in Cleveland has been given emergency approval by the FDA to help patients wean off ventilators. Oberlin-based Synapse Biomedical, working with ...
Respiratory failure is the principal cause of death in patients with amyotrophic lateral sclerosis (ALS), and noninvasive ventilation can prolong life by several months in these individuals.